Citations

Clear

3042 citation(s) found for "Kumar, S".

Gastrointestinal Cancers: Molecular Genetics and Biomarkers
Sharma, Kiran , Bhatia, Vikram , Agarwal, Prasoon , Kumar, Ashok , Sharma, Kiran L

Mayo Clinic

Canadian Journal of Gastroenterology and Hepatology | October 18, 2018 | Volume: 2018 | Issue: No issue available | Pages: 1-2

10.1155/2018/4513860 | PMID 30941325 Get It

Abstract TP213: Retinal Microvascular Abnormalities as Markers of Cerebrovascular Disease: A Meta-Analysis
Dumitrașcu, Oana , Sánchez, Cristina Valencia, Almader‐Douglas, Diana , O’Carroll, Cumara B. , Aguilar, Maria I. , Lyden, Patrick D. , Demaerschalk, Bart M. , Kumar, Gyanendra

Mayo Clinic

Stroke | October 8, 2018 | Volume: 49 | Issue: Suppl_1 | Pages: No page available

10.1161/str.49.suppl_1.tp213 Get It

Introduction: Despite the recognized linkage between retinal microvascular abnormalities and cerebrovascular ischemic diseases (CVD), the retinal findings’ standardization and the degree of association remain unclear. We aimed to investigate the quantitative association between various retinal microvascular signs and CVD. Hypothesis: retinal microvascular abnormalities best predictive of CVD could be identified by synthesizing estimates of CVD risk from population-based studies. Methods: We followed MOOSE guidelines and systematically searched 6 databases through September 2016 for studies evaluating the association between retinal microvascular abnormalities and white matter hyperintense lesions (WMHI), lacunar infarcts (LI), and cerebral infarctions (CI). Adjusted and unadjusted odds ratios (ORs) and confidence intervals were pooled into the analyses using the DerSimonian and Laird random effects model. Study quality and dissemination biases were assessed and integrated. Results: Thirty-four prospective studies encompassing 84,144 patients were eligible for meta-analysis. After adjustment for vascular risk factors, focal arteriolar narrowing was associated with WMHI (OR, 1.24 [1.01-1.79]), LI (OR, 1.77 [1.14-2.74]), and CI (OR, 1.75 [1.14-2.69]). Venular dilation was significantly associated with LI (OR, 1.46 [1.10-1.93]), whereas retinal hemorrhage was associated with WMHI (OR, 2.23 [1.34-3.70]). Arteriovenous nicking was associated with WMHI (OR, 1.51 [1.22-1.88]) and LI (OR, 1.70 [1.05-2.76]). Any retinopathy exhibited significant association with WMHI, LI, and CI. Heterogeneity was significant ( I 2 >50%) for all syntheses except retinal hemorrhages and WMHI, retinopathy and CI ( I 2 =0.0%) and respectively LI ( I 2 =45.80%). Conclusions: Retinal hemorrhages were most highly associated with WMHI. Focal arteriolar narrowing and retinopathy were associated with WMHI, LI, and CI. Our findings may assist in the development of a noninvasive retinal microvascular tool for routine use in CVD research and clinical practice.
Aurora kinase and FGFR3 inhibition results in significant apoptosis in molecular subgroups of multiple myeloma
Painuly, Utkarsh , Ramakrishnan, Vijay , Kimlinger, Teresa K. , Wellik, Linda, Haug, Jessica, Bi, Lintao , Huang, Zhongxia , Kumar, Shaji , Kimlinger, Teresa, Gonsalves, Wilson I. , Rajkumar, S. Vincent

Mayo Clinic

Oncotarget | October 2, 2018 | Volume: 9 | Issue: 77 | Pages: 34582-34594

10.18632/oncotarget.26180 | PMID 30349651 Get It

Olmesartan-induced enteropathy
Onteddu, Nirmal , Pulivarthi, Venkata Siva Krishna Kumar, Ginnavaram, Mihira, Kedika, Ramalinga, Onteddu, Nirmal K

Mayo Clinic

BMJ Case Reports | October 2, 2018 | Volume: 2018 | Issue: No issue available | Pages: bcr-2018-224411

10.1136/bcr-2018-224411 | PMID 30279248 Get It

Olmesartan-induced enteropathy (OIE) typically presents with a constellation of signs and symptoms including chronic diarrhoea, weight loss and villous atrophy on biopsy. We describe a 68-year-old Caucasian woman with a history of hypothyroidism and hypertension who presented to our hospital with recurrent episodes of acute intermittent diarrhoea, nausea, vomiting, renal failure and 15 lbs weight loss. After an extensive workup, she was diagnosed with possible OIE. Cessation of the offending drug resulted in improvement of clinical symptoms and also hospital admissions for severe diarrhoea reinforcing the diagnosis of OIE. Among the adverse effects of drug therapy, diarrhoea is a relatively frequent adverse event accounting for about 7%. This report serves as an addition to existing literature and to increase the awareness of olmesartan-induced sprue-like enteropathy among the primary care physicians and gastroenterologists.
Acute pancreatitis associated with intravenous administration of propofol: evaluation of causality in a systematic review of the literature
Haffar, Samir , Kaur, Ravinder Jeet , Garg, Sushil Kumar , Hyder, Joseph A. , Murad, M. Hassan , Bazerbachi, Fateh , Abu Dayyeh, Barham K, Bazerbachi, F , Murad, M Hassan , Dayyeh, Barham K. Abu

Mayo Clinic

Gastroenterology Report | September 12, 2018 | Volume: 7 | Issue: 1 | Pages: 13-23

10.1093/gastro/goy038 | PMID 30792862 Get It

Utility and prognostic value of 18F‐FDG positron emission tomography‐computed tomography scans in patients with newly diagnosed multiple myeloma
Aljama, Mohammed A. , Sidiqi, M Hasib , Lacy, Martha Q. , Gertz, Morie A. , Dingli, David , Muchtar, Eli , Fonder, Amie , Hayman, Suzanne R. , Hobbs, Miriam, Warsame, Rahma , Kourelis, Taxiarchis , Hwa, Yi L. , Kapoor, Prashant , Kyle, Robert A. , Kumar, Shaji , Buadi, Francis K. , Gertz, Morie A , Fonder, Amie L, Gonsalves, Wilson , Warsame, Rahma , Kourelis, Taxiarchis , Hwa, Yi Lisa, Leung, Nelson , Go, Ronald S , Rajkumar, S Vincent , Muchtar, E , Sidiqi, M Hasib , Dingli, David , Dispenzieri, Angela , Gonsalves, Wilson I. , Leung, Nelson , Go, Ronald S. , Rajkumar, S. Vincent

Mayo Clinic

American Journal of Hematology | September 8, 2018 | Volume: 93 | Issue: 12 | Pages: 1518-1523

10.1002/ajh.25279 | PMID 30194770 Get It

AbstractPositron emission tomography‐computed tomography (PET‐CT) can identify bony lesions, assess disease burden, and detect extramedullary disease (EMD) in patients with multiple myeloma. We retrospectively reviewed records of patients who underwent PET‐CT within 60 days of a new diagnosis (before therapy commenced) to identify the nature and prognostic impact of PET‐CT abnormalities. Patients (N = 313) were seen from April 2005 through June 2017. Of the 234 patients (75%) with focal lesions (FLs), 182 (58%) had at least 3 FLs, 38 (12%) had EMD, and 204 (65%) had documented myelomatous lytic lesions. The median maximum standardized uptake value (SUVmax) for the entire cohort was 5.9 (range 1.5‐48.3). Presence of at least 3 FLs and EMD predicted inferior overall survival (OS); median OS was 57.8 months for patients with 3 or more FLs and 103.6 months for patients with fewer than 3 FLs (P = .003). The median OS was 45.5 and 71.8 months for patients with and without EMD, respectively (P = .004). No clear SUVmax cutoff was predictive of progression‐free survival or OS. PET‐CT is a valuable tool for assessing disease burden and could provide prognostic information about a contemporary cohort of patients with newly diagnosed myeloma who received treatment with novel agents.
Type 1 monoclonal cryoglobulinemia: Clinical presentation and outcomes.
Lacy, Martha Q. , Hayman, Suzanne R. , Kapoor, Prashant , Hwa, Yi L. , Fonder, Amie , Hobbs, Miriam, Zeldenrust, Steven R., Lust, John A., Kyle, Robert A. , Kumar, Shaji , Sidana, Surbhi , Rajkumar, S. Vincent , Dispenzieri, Angela , Gertz, Morie A. , Buadi, Francis K. , Dingli, David , Gonsalves, Wilson I. , Leung, Nelson

Mayo Clinic

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: 8062-8062

10.1200/jco.2016.34.15_suppl.8062 Get It

Importance of pharmacovigilance in the era of small molecules: Role of pharmacist consultation with ixazomib (IXA) in multiple myeloma (MM).
Finnes, Heidi D. , Kumar, Shaji , LaPlant, Betsy, Lacy, Martha Q. , Merten, Julianna A., Bartoo, Gabriel , Kapoor, Prashant , Gertz, Morie A. , Buadi, Francis K. , Dispenzieri, Angela , McCullough, Kristen , Rajkumar, S. Vincent

Mayo Clinic

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: 8058-8058

10.1200/jco.2016.34.15_suppl.8058 Get It

Changes in serum alkaline phosphatase levels to predict response to ixazomib-based therapy in patients with newly diagnosed multiple myeloma.
Tandon, Nidhi , Lacy, Martha Q. , Kapoor, Prashant , Hwa, Yi L. , Fonder, Amie , Hobbs, Miriam, Hayman, Suzanne R. , Zeldenrust, Steven R., Lust, John A., Kumar, Shaji , Buadi, Francis K. , Leung, Nelson , Go, Ronald S. , Dingli, David , Gertz, Morie A. , Lin, Yi , Dispenzieri, Angela , Drake, Matthew T. , Gonsalves, Wilson I. , Rajkumar, S. Vincent

Mayo Clinic

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: 8053-8053

10.1200/jco.2016.34.15_suppl.8053 Get It